FGF9 and prostate cancer: Interruption of Klf5 acetylation in Pten-deficient prostate cancer cells signaled iCAFs through TNF-α to promote FGF9 release, which in turn activated FGFR1 signaling in prostate cancer cells (Figures 4–7).